| Literature DB >> 26776889 |
Jonathan Rodrigues1, Carrie Caruthers1, Roua Azmeh1, Mark S Dykewicz1, Raymond G Slavin1, Alan P Knutsen1.
Abstract
Fungi cause a wide spectrum of fungal diseases of the upper and lower airways. There are three main phyla involved in allergic fungal disease: (1) Ascomycota (2) Basidiomycota (3) Zygomycota. Allergic fungal rhinosinusitis (AFRS) causes chronic rhinosinusitis symptoms and is caused predominantly by Aspergillus fumigatus in India and Bipolaris in the United States. The recommended treatment approach for AFRS is surgical intervention and systemic steroids. Allergic bronchopulmonary aspergillosis (APBA) is most commonly diagnosed in patients with asthma or cystic fibrosis. Long term systemic steroids are the mainstay treatment option for ABPA with the addition of an antifungal medication. Fungal sensitization or exposure increases a patient's risk of developing severe asthma and has been termed severe asthma associated with fungal sensitivity (SAFS). Investigating for triggers and causes of a patient's asthma should be sought to decrease worsening progression of the disease.Entities:
Keywords: ABPA; ABPM; AFRS; AFS; Fungal allergy; allergic bronchopulmonary aspergillosis; allergic bronchopulmonary mycoses; allergic fungal sinusitis; allergy; fungal rhinosinusitis; fungal sinusitis; severe asthma associated with fungal sensitivity
Mesh:
Substances:
Year: 2016 PMID: 26776889 DOI: 10.1586/1744666X.2016.1142874
Source DB: PubMed Journal: Expert Rev Clin Immunol ISSN: 1744-666X Impact factor: 4.473